Chemours Co (CC) stock
Close on Nov 11, 2026Market cap $2.06BP/E –Yield 3.74%
Chemours Co grew revenue 0.1% to $5.84B over the twelve months to Sep 30, 2026. Free cash flow was $211.00M. At the latest close the market valued the company at $2.06B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $2.06B
- P/E ratio
- –
- Price to sales
- 0.35
- Price to book
- 13.32
- Dividend yield
- 3.74%
- Free cash flow yield
- 10.22%
Fundamentals
- Revenue
- $5.84B
- Net income
- -$154.00M
- EPS, diluted
- -$1.02
- Free cash flow
- $211.00M
- Book value per share
- $1.02
- Diluted shares
- 152M
Trading
- Next earnings
- Feb 18, 2027 (estimated, after the close)
- Previous close
- $13.48
- Open
- $13.74
- Day's range
- $13.58 – $13.98
- Volume
- 1,499,892
- Average volume (20 days)
- 2,605,377
- Index membership
- S&P SmallCap 600 (since May 2025), Russell 2000 (since Jun 2025), Russell 3000
- Beta (5 years)
- 1.57
- 52-week range
- $10.44 – $28.67
- RSI (14 days)
- 54.0
- Volatility (1 year)
- 60.4%
- Relative volume
- 0.64×
- WACC
- 7.5%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CC | S&P 500 | Difference | CC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.8% | -2.4% | +3.2 pts | ||
| 3 months | -6.8% | -1.2% | −5.6 pts | ||
| Year to date | +18.1% | +12.3% | +5.8 pts | ||
| 1 year | +10.8% | +12.4% | −1.6 pts | ||
| 3 years | -37.5% | +78.8% | −116.3 pts | -14.5% | +21.4% |
| 5 years | -49.9% | +75.2% | −125.1 pts | -12.9% | +11.9% |
| 10 years | -8.0% | +311.1% | −319.1 pts | -0.8% | +15.2% |
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Net income
EPS, diluted
Free cash flow
Press releases
Releases Chemours filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Update
- Results
About Chemours
Chemicals & Allied Products
The company provides performance chemicals and materials across operating segments that include Thermal & Specialized Solutions, Advanced Performance Materials, Titanium Technologies, and Performance Chemicals and Intermediates. Its portfolio features industrial products such as titanium dioxide pigments, Freon refrigerants, foam propellants, fluoromaterials, and glycolic acid solutions. These chemical products and advanced performance solutions are supplied to diverse commercial customers, industrial clients, and manufacturers across multiple specialized end markets.
Company profile, executives and historyChemours stock: common questions
What is Chemours's stock price?
CC closed at $13.72 on Nov 11, 2026, up 1.78% on the day. Over the past 52 weeks it traded between $10.44 and $28.67.
What is Chemours's market cap?
Chemours was worth $2.06B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CC's P/E ratio?
Chemours lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.02), so it has no meaningful P/E ratio.
How much revenue does Chemours make?
Chemours reported revenue of $5.84B for the twelve months to Sep 30, 2026, up 0.1% from a year earlier.
Does Chemours pay a dividend?
Yes. Chemours paid $0.51 per share over the last twelve months, a yield of 3.74% at the latest price.
When does Chemours report earnings next?
Chemours is expected to report Q4 FY2026 results on Feb 18, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has CC stock performed over the past year?
Including dividends, CC returned +10.8% over the past year, against +12.4% for the S&P 500.
How many CC shares are sold short?
15M shares were sold short at the latest FINRA report, 9.76% of the float, or 6.8 days of average trading volume.
Who are Chemours's competitors?
Companies most similar to Chemours by business, industry and size include HUN, SOLS, OLN, IOSP, EMN.
See a number that looks wrong?